BBTV

About Us

Stem Cells at a Glance – Stem Cell Review (EP1)

« Lee Buckler Reports from the 2009 Phacilitate Cell & Gene Therapy Forum
ISIS – Isis Pharma CEO Stanley Crooke Interviewed by Mark Monane »
  • Chapters
  • 1. Different Types of Stem Cells & Future Medical Applications
  • 2. Stem Cell Interaction and the iPS Cell Revolution
  • 3. The Business & Politics of Stem Cells

1. Different Types of Stem Cells & Future Medical Applications


What are the differences between embryonic, adult and induced pluripotent stem cells? Where do the experts expect the next medical application will be for stem cells? Do stem cells promote regeneration?


2. Stem Cell Interaction and the iPS Cell Revolution


How are cell types interacting? How can induced pluripotent stem (iPS) cells revolutionize drug discovery?


3. The Business & Politics of Stem Cells


Can cell therapies be made into a viable business? How close are we to finding the right business model? Are investors interested in stem cells today? What is the political and ethical landscape like now that the Obama administration has taken over the White House?


This is the Episode 1 of the Stem Cell Review, aired on October 1st, 2009

Related Videos:

  1. Mesenchymal Stem Cells and Connective Disorders – Stem Cell Review (EP6)
  2. Stem Cells & Diabetes – Stem Cell Review (EP8)
  3. Neural Stem Cells and CNS Disorder – Stem Cell Review (EP7)
  4. Tools for Drug Screening – Stem Cell Review (EP4)
  5. Autoimmune Diseases & Blood Disorders – Stem Cell Review (EP9)
  6. Stem Cells (Best of the Web)
  7. Tissue Repair – Stem Cell Review (EP10)
  8. Biological Processes & Industrial Production – Stem Cell Review (EP3)
  9. Looking Forward to 2015 – Stem Cell Review (EP5)
  10. Vaccine and Antibody Production from Stem Cells, Vivalis
« Lee Buckler Reports from the 2009 Phacilitate Cell & Gene Therapy Forum
ISIS – Isis Pharma CEO Stanley Crooke Interviewed by Mark Monane »

Post a Comment

Click here to cancel reply.

Your email is never published nor shared. Required fields are marked *

*
*
  • About the Series


    The Stem Cell Review is a 10-part original series on the science, medical applications, and business of stem cells.


    This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field.


    The Stem Cell Review is a BioBusiness.TV Original Program, presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.

  • Related Videos

    1. Mesenchymal Stem Cells and Connective Disorders – Stem Cell Review (EP6)
    2. Stem Cells & Diabetes – Stem Cell Review (EP8)
    3. Neural Stem Cells and CNS Disorder – Stem Cell Review (EP7)
    4. Tools for Drug Screening – Stem Cell Review (EP4)
    5. Autoimmune Diseases & Blood Disorders – Stem Cell Review (EP9)
    6. Stem Cells (Best of the Web)
    7. Tissue Repair – Stem Cell Review (EP10)
    8. Biological Processes & Industrial Production – Stem Cell Review (EP3)
    9. Looking Forward to 2015 – Stem Cell Review (EP5)
    10. Vaccine and Antibody Production from Stem Cells, Vivalis
  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.

  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.

  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.

  • COPYRIGHT © 2011 BIO BUSINESS TV, INC. All Rights Reserved